AF
OGEN icon

Allworth Financial’s Oragenics OGEN Stock Holding History

Allworth Financial’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-334
Closed -$438 – 5207
2025
Q3 		$438 Buy
+334
New +$422 ﹤0.01% 4471

Other funds holding OGEN

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allworth Financial's OGEN Position: Q4 2025 in Review

Allworth Financial sold out of Oragenics (OGEN) in Q4 2025, closing a stake of 334 shares — an estimated $438 sold.

Allworth Financial first reported a position in OGEN in Q3 2025 and held it in 1 quarter. The position peaked at $438 in Q3 2025. 18 funds tracked by Wall St. Rank hold OGEN as of Q4 2025.

  • Allworth Financial reported no remaining Oragenics position as of Q4 2025 after selling out during the quarter.
  • Allworth Financial sold 334 Oragenics shares in Q4 2025, an estimated $438.
  • Allworth Financial first reported a position in Oragenics in Q3 2025 and held it in 1 quarter.
  • Allworth Financial's Oragenics position peaked at $438 in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Oragenics as of Q4 2025.

Based on Allworth Financial's 13F filing for Q4 2025, filed 5 Feb 2026.